Long Term Treatment of Multiple Sclerosis with Glatiramer Acetate: Natural History of the Subtypes of Anti-Glatiramer Acetate Antibodies and Their Correlation with Clinical Efficacy

被引：0
|
作者：
Brenner, Talma
Teitelbaum, Dvora
Sicsic, Camille
Karussis, Dimitrios
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A423 / A423
页数：1
相关论文
共 50 条
  • [21] Spasticity in multiple sclerosis and role of glatiramer acetate treatment
    Eustasio Meca-Lallana, Jose
    Hernandez-Clares, Rocio
    Carreon-Guarnizo, Ester
    BRAIN AND BEHAVIOR, 2015, 5 (09):
  • [22] Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective
    Racke, Michael K.
    Lovett-Racke, Amy E.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (04): : 1887 - 1890
  • [23] Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis (vol 72, pg 1411, 2015)
    Bourdette, D.
    Hartung, D.
    JAMA NEUROLOGY, 2015, 72 (12) : 1537 - 1537
  • [24] Factors Associated with Glatiramer Acetate Efficacy in Japanese Multiple Sclerosis
    Tanaka, Eizo
    Watanabe, Mitsuru
    Fukumoto, Shoko
    Suezumi, Koki
    Matsushita, Takuya
    Isobe, Noriko
    Masaki, Katsuhisa
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP34 - NP35
  • [25] THE LONG-TERM VALUE OF GLATIRAMER ACETATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN THE NETHERLANDS
    Wilson, L. E.
    Prufert, A.
    VALUE IN HEALTH, 2014, 17 (07) : A398 - A399
  • [26] Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis
    Sellebjerg, F.
    Hedegaard, C. J.
    Krakauer, M.
    Hesse, D.
    Lund, H.
    Nielsen, C. H.
    Sondergaard, H. B.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (03) : 305 - 313
  • [27] Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?
    Mirabella, Massimiliano
    Annovazzi, Pietro
    Brownlee, Wallace
    Cohen, Jeffrey A.
    Kleinschnitz, Christoph
    Wolf, Christian
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [28] Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis
    Hwang, L
    Orengo, I
    CUTIS, 2001, 68 (04): : 287 - 288
  • [29] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [30] Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate
    Windhagen, A
    Maniak, S
    Marckmann, S
    Wilkening, A
    Lindert, RB
    Heidenreich, F
    Blasczyk, R
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03): : 415 - 416
12345